Shanghai Pharmaceuticals Holding Co Ltd (601607) — Long-term Investment Intensity
Shanghai Pharmaceuticals Holding Co Ltd (601607) has a Long-term Investment Intensity of 4.0% as of December 2019. Long-term investments of CN¥5.43 Billion represent 4.0% of total assets of CN¥137.03 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 601607 financial resilience to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Shanghai Pharmaceuticals Holding Co Ltd Long-term Investment Intensity (2015–2019)
This chart shows how Shanghai Pharmaceuticals Holding Co Ltd's Long-term Investment Intensity has evolved across 5 annual periods from 2015 to 2019. As of December 2019, the intensity stands at 4.0%, reflecting long-term investments of CN¥5.43 Billion against total assets of CN¥137.03 Billion CNY. For the complete balance sheet picture, see Shanghai Pharmaceuticals Holding Co Ltd balance sheet assets.
Annual Long-term Investment Intensity for Shanghai Pharmaceuticals Holding Co Ltd (2015–2019)
The table below presents the year-by-year Long-term Investment Intensity for Shanghai Pharmaceuticals Holding Co Ltd from 2015 to 2019, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read how much debt does Shanghai Pharmaceuticals Holding Co Ltd carry for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 4.0% | CN¥5.43 Billion | CN¥137.03 Billion | ▲ +0.3 pp |
| 2018 | 3.7% | CN¥4.65 Billion | CN¥126.88 Billion | ▼ -1.4 pp |
| 2017 | 5.1% | CN¥4.80 Billion | CN¥94.34 Billion | ▼ -0.3 pp |
| 2016 | 5.4% | CN¥4.50 Billion | CN¥82.74 Billion | ▲ +0.2 pp |
| 2015 | 5.3% | CN¥3.92 Billion | CN¥74.34 Billion | — |